Acker, A. V., Rousseau, E., Wu, W., Corradi, J., Corwin, W., Scopel, M., Wang, X. (., Landrette, S., Gough, S. (2025). ARV-393, a PROTAC BCL6 degrader, combined with the CD20×CD3 bispecific glofitamab in a preclinical model of high-grade B-cell lymphoma (HGBCL). Blood. https://doi.org/10.1182/blood-2025-1520